322 related articles for article (PubMed ID: 32652231)
21. Convalescent plasma to treat COVID-19.
Bloch EM
Blood; 2020 Aug; 136(6):654-655. PubMed ID: 32761219
[No Abstract] [Full Text] [Related]
22. Management of COVID-19 Virus Infection by Convalescent Plasma.
Cheraghali AM; Abolghasemi H; Eshghi P
Iran J Allergy Asthma Immunol; 2020 May; 19(S1):3-6. PubMed ID: 32534509
[TBL] [Abstract][Full Text] [Related]
23. Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.
Ahn JY; Sohn Y; Lee SH; Cho Y; Hyun JH; Baek YJ; Jeong SJ; Kim JH; Ku NS; Yeom JS; Roh J; Ahn MY; Chin BS; Kim YS; Lee H; Yong D; Kim HO; Kim S; Choi JY
J Korean Med Sci; 2020 Apr; 35(14):e149. PubMed ID: 32281317
[TBL] [Abstract][Full Text] [Related]
24. Recruitment Strategy for Potential COVID-19 Convalescent Plasma Donors.
Andersen KJ; Klassen SA; Larson KF; Ripoll JG; Senefeld JW; Clayburn AJ; Shepherd JRA; Tseng AS; Wiggins CC; Murphy BM; Ford SK; Johnson CP; Miller AD; Baker SE; Wright RS; Winters JL; Stubbs JR; Joyner MJ; van Buskirk CM
Mayo Clin Proc; 2020 Nov; 95(11):2343-2349. PubMed ID: 33153626
[No Abstract] [Full Text] [Related]
25. Prioritizing clinical research studies during the COVID-19 pandemic: lessons from New York City.
Gulick RM; Sobieszczyk ME; Landry DW; Hollenberg AN
J Clin Invest; 2020 Sep; 130(9):4522-4524. PubMed ID: 32692726
[No Abstract] [Full Text] [Related]
26. Immunoglobulins or convalescent plasma to tackle COVID-19: buying time to save lives - current situation and perspectives.
Tamburello A; Marando M
Swiss Med Wkly; 2020 Apr; 150():w20264. PubMed ID: 32343358
[No Abstract] [Full Text] [Related]
27. COVID-19, plasma, and hypogammaglobulinemia.
Murphy MF; Dzik S
Blood; 2020 Nov; 136(20):2245-2246. PubMed ID: 33180920
[No Abstract] [Full Text] [Related]
28. Vaccines, convalescent plasma, and monoclonal antibodies for covid-19.
Sewell HF; Agius RM; Kendrick D; Stewart M
BMJ; 2020 Jul; 370():m2722. PubMed ID: 32646867
[No Abstract] [Full Text] [Related]
29. Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement.
Fleming AB; Raabe V
J Clin Virol; 2020 Jun; 127():104388. PubMed ID: 32361326
[No Abstract] [Full Text] [Related]
30. Active Therapy with Passive Immunotherapy May Be Effective in the Fight against COVID-19.
Morabito CJ; Gangadharan B
Clin Transl Sci; 2020 Sep; 13(5):835-837. PubMed ID: 32420691
[No Abstract] [Full Text] [Related]
31. How likely are COVID-19 interventions to benefit the sickest patients?
Perner A; Tirupakuzhi Vijayaraghavan BK; Venkatesh B
Intensive Care Med; 2020 Jul; 46(7):1441-1444. PubMed ID: 32519004
[No Abstract] [Full Text] [Related]
32. Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline.
Abid MA; Nunley L; Abid MB
Front Immunol; 2020; 11():1294. PubMed ID: 32582221
[No Abstract] [Full Text] [Related]
33. Convalescent Plasma Therapy in Patients With Severe or Life-Threatening COVID-19: A Metadata Analysis.
Rabelo-da-Ponte FD; Silvello D; Scherer JN; Ayala AR; Klamt F
J Infect Dis; 2020 Oct; 222(9):1575-1578. PubMed ID: 32777038
[No Abstract] [Full Text] [Related]
34. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19.
Nnaji CA; Iwu CJ; Ndwandwe DE; Jordan P; Wiysonge CS
S Afr Med J; 2020 Jul; 110(8):759-760. PubMed ID: 32880303
[TBL] [Abstract][Full Text] [Related]
35. Use of convalescent plasma in hospitalized patients with COVID-19: case series.
Hegerova L; Gooley TA; Sweerus KA; Maree C; Bailey N; Bailey M; Dunleavy V; Patel K; Alcorn K; Haley R; Johnsen JM; Konkle BA; Lahti AC; Alexander ML; Goldman JD; Lipke A; Lim SJ; Sullivan MD; Pauk JS; Pagel JM
Blood; 2020 Aug; 136(6):759-762. PubMed ID: 32559767
[TBL] [Abstract][Full Text] [Related]
36. [Intensive care unit treatment for patients suffering from COVID-19: the Neuchâtel experience].
Haller ML; Brunner ME; Zender HO
Rev Med Suisse; 2020 Nov; 16(716):2284-2286. PubMed ID: 33237646
[TBL] [Abstract][Full Text] [Related]
37. Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities.
Farrugia A
Transfus Clin Biol; 2020 Aug; 27(3):167-168. PubMed ID: 32563550
[No Abstract] [Full Text] [Related]
38. Plasma-derived therapy: can the survivors of COVID-19 help the defenseless?
Majbour N; El-Agnaf O
Diagnosis (Berl); 2020 Nov; 7(4):373-376. PubMed ID: 32692700
[TBL] [Abstract][Full Text] [Related]
39. The therapeutic potential of convalescent plasma therapy on treating critically-ill COVID-19 patients residing in respiratory care units in hospitals in Baghdad, Iraq.
Rasheed AM; Fatak DF; Hashim HA; Maulood MF; Kabah KK; Almusawi YA; Abdulamir AS
Infez Med; 2020 Sep; 28(3):357-366. PubMed ID: 32920571
[TBL] [Abstract][Full Text] [Related]
40. Convalescent plasma for patients with COVID-19.
Zeng F; Chen X; Deng G
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12528. PubMed ID: 32398379
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
